Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Fulcrum Therapeutics Inc (NASDAQ: FULC) closed the day trading at $4.48 down -8.38% from the previous closing price of $4.89. In other words, the price has decreased by -$8.38 from its previous closing price. On the day, 0.65 million shares were traded. FULC stock price reached its highest trading level at $4.89 during the session, while it also had its lowest trading level at $4.47.
Ratios:
For a better understanding of FULC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.44 and its Current Ratio is at 18.44. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on September 13, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $17 previously.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on September 12, 2024, whereas the target price for the stock was revised from $15 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 07 ’24 when Tourangeau Greg sold 236 shares for $7.76 per share. The transaction valued at 1,831 led to the insider holds 11,571 shares of the business.
Tourangeau Greg sold 4,884 shares of FULC for $57,219 on Mar 08 ’24. The Vice President, Finance now owns 11,807 shares after completing the transaction at $11.72 per share. On Mar 04 ’24, another insider, Sapir Alex, who serves as the insider of the company, bought 43,360 shares for $11.35 each. As a result, the insider paid 492,028 and bolstered with 43,360 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FULC now has a Market Capitalization of 241645376 and an Enterprise Value of -41979260. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.99 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at -0.514 whereas that against EBITDA is 1.359.
Stock Price History:
Over the past 52 weeks, FULC has reached a high of $13.70, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is 15.71%, while the 200-Day Moving Average is calculated to be -28.31%.
Shares Statistics:
Over the past 3-months, FULC traded about 884.40K shares per day on average, while over the past 10 days, FULC traded about 973820 shares per day. A total of 53.94M shares are outstanding, with a floating share count of 45.46M. Insiders hold about 15.71% of the company’s shares, while institutions hold 91.76% stake in the company. Shares short for FULC as of 1730332800 were 4970723 with a Short Ratio of 4.81, compared to 1727654400 on 5896079. Therefore, it implies a Short% of Shares Outstanding of 4970723 and a Short% of Float of 9.92.
